TTD | Drug: D0DV3T

Drug General Information
Drug ID	D0DV3T
Former ID	DIB006387
Drug Name	Epoetin zeta
Indication	Anemia [ICD9: 280-285; ICD10:D50-D64]		Phase 3	[529265]
Company	Hospira
Target and Pathway
Target(s)	Erythropoietin Receptor	Target Info	Modulator	[529757]
KEGG Pathway	Cytokine-cytokine receptor interaction
	PI3K-Akt signaling pathway
	Jak-STAT signaling pathway
	Hematopoietic cell lineage
NetPath Pathway	TGF_beta_Receptor Signaling Pathway
Pathway Interaction Database	Signaling events mediated by Stem cell factor receptor (c-Kit)
Pathway Interaction Database	EPO signaling pathway
WikiPathways	EPO Receptor Signaling
References
Ref 529265	Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment. Curr Med Res Opin. 2008 Mar;24(3):625-37.
Ref 529757	Long-term safety and tolerability of epoetin zeta, administered intravenously, for maintenance treatment of renal anemia. Adv Ther. 2008 Nov;25(11):1215-28.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information